Epstein-barr virus, the immune system, and associated diseases
- PMID:21687403
- PMCID: PMC3109484
- DOI: 10.3389/fmicb.2011.00005
Epstein-barr virus, the immune system, and associated diseases
Abstract
Host immune system is designed (or evolved) to fight against different pathogens. Many viruses infect the immune cells for the propagation of new progenies, thus the infection may modulate the host immune homeostasis. It has been more than 45 years since the discovery of Epstein-Barr virus (EBV) from a Burkitt's lymphoma derived cell line. The ability of EBV to transform primary B cells in vitro leads to the suggestion for its oncogenic potential. However, except the clear understanding of the role of EBV in post-transplantation lymphoproliferative disease, it remains ambiguous why such a ubiquitous virus causes malignant diseases only in a very small subset of individuals. Possible explanation is that EBV may cooperate with other environmental and host genetic factors and lead to the development of EBV associated neoplastic diseases. In addition to infecting B cells, recent studies revealed that EBV may impact host immune system more broadly than previously thought, for example the development of regulatory NKT subsets. Instead of an intensive review, this article aims to provide a linkage to recent advances on the interplay between EBV and host immune system and to inspire further studies on EBV related diseases, especially autoimmune diseases.
Keywords: Epstein–Barr virus; autoimmune disease; immune system.
Similar articles
- Epstein-Barr virus-associated lymphoproliferative disorders.Grywalska E, Markowicz J, Grabarczyk P, Pasiarski M, Roliński J.Grywalska E, et al.Postepy Hig Med Dosw (Online). 2013 May 24;67:481-90. doi: 10.5604/17322693.1050999.Postepy Hig Med Dosw (Online). 2013.PMID:23752600Review.
- MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune ControlIn Vivo.Murer A, Rühl J, Zbinden A, Capaul R, Hammerschmidt W, Chijioke O, Münz C.Murer A, et al.mBio. 2019 Jan 15;10(1):e01941-18. doi: 10.1128/mBio.01941-18.mBio. 2019.PMID:30647153Free PMC article.
- Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease.Aguayo-Hiraldo P, Arasaratnam R, Rouce RH.Aguayo-Hiraldo P, et al.Bol Med Hosp Infant Mex. 2016 Jan-Feb;73(1):31-40. doi: 10.1016/j.bmhimx.2015.11.007. Epub 2016 Feb 23.Bol Med Hosp Infant Mex. 2016.PMID:29421230
- An Overview of Epstein-Barr Virus: from Discovery to Future Directions for Treatment and Prevention.Andersson J.Andersson J.Herpes. 2000 Oct;7(3):76-82.Herpes. 2000.PMID:11867007
- From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases.Okano M, Gross TG.Okano M, et al.Pediatr Hematol Oncol. 2001 Oct-Nov;18(7):427-42. doi: 10.1080/088800101750476014.Pediatr Hematol Oncol. 2001.PMID:11594706Review.
Cited by
- Prevalence of Human papillomavirus (HPV) and Epstein-Barr virus (EBV) in oral and oropharyngeal squamous cell carcinoma in south-eastern Poland.Polz-Gruszka D, Morshed K, Stec A, Polz-Dacewicz M.Polz-Gruszka D, et al.Infect Agent Cancer. 2015 Oct 12;10:37. doi: 10.1186/s13027-015-0031-z. eCollection 2015.Infect Agent Cancer. 2015.PMID:26462255Free PMC article.
- Prevalence and association of Epstein-Barr virus infection with sinonasal inverted papilloma and sinonasal squamous cell carcinoma in the northeastern Thai population.Nukpook T, Ekalaksananan T, Teeramatwanich W, Patarapadungkit N, Chaiwiriyakul S, Vatanasapt P, Aromseree S, Pientong C.Nukpook T, et al.Infect Agent Cancer. 2020 Jun 24;15:43. doi: 10.1186/s13027-020-00308-5. eCollection 2020.Infect Agent Cancer. 2020.PMID:32595759Free PMC article.
- Could Immune Checkpoint Disorders and EBV Reactivation Be Connected in the Development of Hematological Malignancies in Immunodeficient Patients?Mertowska P, Mertowski S, Smolak K, Kita G, Guz K, Kita A, Pasiarski M, Smok-Kalwat J, Góźdź S, Grywalska E.Mertowska P, et al.Cancers (Basel). 2023 Sep 29;15(19):4786. doi: 10.3390/cancers15194786.Cancers (Basel). 2023.PMID:37835480Free PMC article.
- EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis.Vincent-Bugnas S, Vitale S, Mouline CC, Khaali W, Charbit Y, Mahler P, Prêcheur I, Hofman P, Maryanski JL, Doglio A.Vincent-Bugnas S, et al.PLoS One. 2013 Dec 19;8(12):e80336. doi: 10.1371/journal.pone.0080336. eCollection 2013.PLoS One. 2013.PMID:24367478Free PMC article.
- A case of non-paraneoplastic anti-N-methyl d-aspartate receptor encephalitis presenting as a neuropsychiatric disorder.Yoga B, Kunc M, Ahmed F.Yoga B, et al.SAGE Open Med Case Rep. 2014 Nov 21;2:2050313X14558902. doi: 10.1177/2050313X14558902. eCollection 2014.SAGE Open Med Case Rep. 2014.PMID:27489663Free PMC article.
References
- Ascherio A., Munger K. L. (2007). Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 61, 288–299 - PubMed
- Azakami K., Sato T., Araya N., Utsunomiya A., Kubota R., Suzuki K., Hasegawa D., Izumi T., Fujita H., Aratani S., Fujii R., Yagishita N., Kamijuku H., Kanekura T., Seino K., Nishioka K., Nakajima T., Yamano Y. (2009). Severe loss of invariant NKT cells exhibiting anti-HTLV-1 activity in patients with HTLV-1-associated disorders. Blood 114, 3208–321510.1182/blood-2009-02-203042 - DOI - PMC - PubMed
- Berzofsky J. A., Terabe M. (2008). NKT cells in tumor immunity: opposing subsets define a new immunoregulatory axis. J. Immunol. 180, 3627–3635 - PubMed
- Brady G., Macarthur G. J., Farrell P. J. (2008). Epstein–Barr virus and Burkitt lymphoma. Postgrad. Med. J. 84, 372–377 - PubMed
LinkOut - more resources
Full Text Sources